Back to search

Article

Impact of disease-modifying therapies in adults with concomitant psoriatic and metabolic liver disease with integrated immunoprofiling

2026-07-09

Abstract excerpt

Psoriatic disease (PsD) is associated with metabolic dysfunction-associated steatotic liver disease (MASLD), but the hepatic effects of biologic therapies are unclear. We evaluated paired liver MRI and multi-modal immunoprofiling in PsD patients initiating new systemic therapy. COLIPSO is a prospective cohort of adults with moderate-to-severe psoriasis or psoriatic arthritis (PsA) starting a new conventional synth...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
de59b816-483a-54b6-852b-2548d39fd305
DOI
10.64898/2026.07.06.26357384
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Impact of disease-modifying therapies in adults with concomitant psoriatic and metabolic liver disease with integrated immunoprofilingDOI 10.64898/2026.07.06.26357384
Select a neighboring publication to make it the new centre.